Bedaquiline - Pretomanid - Linezolid Regimens Compared for XDR TB

Overall risk - benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Pharmacy, Pulmonology, Journal, Source Type: news